Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
1 clinical trials · Condition
◉ Watch Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
| Record | Firm | Date |
|---|---|---|
| Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder (NCT05786040) | Timothy Voorhees | 2023-03-23 |
Track Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder automatically
Every clearance here is in the API, with alerts when new ones post.